Integrase and integration: biochemical activities of HIV-1 integrase

被引:0
|
作者
Olivier Delelis
Kevin Carayon
Ali Saïb
Eric Deprez
Jean-François Mouscadet
机构
[1] Ecole Normale Supérieure de Cachan,LBPA, CNRS
[2] Hôpital Saint-Louis,CNRS
来源
关键词
Long Terminal Repeat; Raltegravir; Integrase Inhibitor; Strand Transfer; Elvitegravir;
D O I
暂无
中图分类号
学科分类号
摘要
Integration of retroviral DNA is an obligatory step of retrovirus replication because proviral DNA is the template for productive infection. Integrase, a retroviral enzyme, catalyses integration. The process of integration can be divided into two sequential reactions. The first one, named 3'-processing, corresponds to a specific endonucleolytic reaction which prepares the viral DNA extremities to be competent for the subsequent covalent insertion, named strand transfer, into the host cell genome by a trans-esterification reaction. Recently, a novel specific activity of the full length integrase was reported, in vitro, by our group for two retroviral integrases (HIV-1 and PFV-1). This activity of internal cleavage occurs at a specific palindromic sequence mimicking the LTR-LTR junction described into the 2-LTR circles which are peculiar viral DNA forms found during viral infection. Moreover, recent studies demonstrated the existence of a weak palindromic consensus found at the integration sites. Taken together, these data underline the propensity of retroviral integrases for binding symmetrical sequences and give perspectives for targeting specific sequences used for gene therapy.
引用
收藏
相关论文
共 50 条
  • [41] Styrylquinazoline derivatives as HIV-1 integrase inhibitors
    Lee, JY
    Park, JH
    Lee, SJ
    Park, H
    Lee, YS
    ARCHIV DER PHARMAZIE, 2002, 335 (06) : 277 - 282
  • [42] Strategies for identification of HIV-1 integrase inhibitors
    Ramcharan, Joseph
    Skalka, Anna Marie
    FUTURE VIROLOGY, 2006, 1 (06) : 717 - 731
  • [43] Design and discovery of HIV-1 integrase inhibitors
    Neamati, N
    Sunder, S
    Pommier, Y
    DRUG DISCOVERY TODAY, 1997, 2 (11) : 487 - 498
  • [44] HIV-1 integrase pharmacophore identification.
    Hong, HX
    Wang, SM
    Nicklause, MC
    Milne, GWA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 38 - COMP
  • [45] Screening and identification of inhibitors on HIV-1 integrase
    Zou Yuan
    Zhan Jin-Biao
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2007, 34 (09) : 965 - 970
  • [46] HIV-1 Integrase Multimerization as a Therapeutic Target
    Feng, Lei
    Larue, Ross C.
    Slaughter, Alison
    Kessl, Jacques J.
    Kvaratskhelia, Mamuka
    FUTURE OF HIV-1 THERAPEUTICS: RESISTANCE IS FUTILE?, 2015, 389 : 93 - 119
  • [47] HIV-1 Integrase Inhibitors That Are Active against Drug-Resistant Integrase Mutants
    Smith, Steven J.
    Zhao, Xue Zhi
    Passos, Dario Oliveira
    Lyumkis, Dmitry
    Burke, Terrence R., Jr.
    Hughes, Stephen H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)
  • [48] HIV-1 integrase SUMOylation and viral replication
    Alessia Zamborlini
    Audrey Coiffic
    Guillaume Beauclair
    Olivier Delelis
    Joris Paris
    Fabien Magne
    Yashuiro Koh
    Marie-Lou Giron
    Joelle Tobaly-Tapiero
    Stephane Emiliani
    Alan Engelman
    Hugues de The
    Ali Saib
    Retrovirology, 8 (Suppl 2)
  • [49] Allosteric inhibition of HIV-1 integrase activity
    Engelman, Alan
    Kessl, Jacques J.
    Kvaratskhelia, Mamuka
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2013, 17 (03) : 339 - 345
  • [50] Stereospecificity of reactions catalyzed by HIV-1 integrase
    Gerton, JL
    Herschlag, D
    Brown, PO
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (47) : 33480 - 33487